2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. Doi: 10.1056/NEJM199309303291401.

3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53. Doi: 10.1016/S0140-6736(98) 07019-6.

4. Дедов И.И., Шестакова М.В., Майоров А.Ю. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 11-е изд. М., 2023.

5. Nathan D.M., Cleary P.A., Backlund J.-Y.C., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53. Doi: 10.1056/NEJMoa052187.

6. Patel A., MacMahon S., et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72 . Doi: 10.1056/NEJMoa0802987.

7. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39. Doi: 10.1056/NEJMoa0808431.

8. Gerstein H.C., Miller M.E., et al.; ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364:818–28. Doi: 10.1056/NEJMoa1006524.

9. Russo G., Di Bartolo P., Candido R., et al. The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care. Diab Res Clin Pract. 2023;199:110672. Doi: 10.1016/j.diabres.2023.110672.

10. Gagliardino J.J., Chantelot J.M., Domenger C., et al. Impact of diabetes education and self-management on the quality of care for people with type 1 diabetes mellitus in the Middle East (the International Diabetes Mellitus Practices Study, IDMPS). Diab Res Clin Pract. 2019;9(147):29–36. Doi: 10.1016/j.diabres.2018.09.008.

11. Grady M., Katz L.B., Cameron H., Levy B.L. Diabetes app-related text messages from health care professionals in conjunction with a new wireless glucose meter with a color range indicator improves glycemic control in patients with type 1 and type 2 diabetes: randomized controlled trial. JMIR Diabetes.2017;2(2):e19. Doi: 10.2196/diabetes.7454.

12. Pleus S., Freckmann G., Schauer S., et al. Self-monitoring of blood glucose as an integral part in the management of people with Type 2 Diabetes Mellitus. Diab Ther. 2022;13:829–46. Doi: 10.1007/s13300-022-01254-8.

13. Williams D.M., Parsons S.N., Dunseath G.J., et al. The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: The SMBG study, a 12-month randomised controlled trial. Diab Metab Syndr. 2020;14:101–6. Doi: 10.1016/j.dsx.2020.01.006.

14. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 11-й выпуск. М., 2023.

15. ElSayed N.A., Aleppo G., Aroda V.R., et al. 7. Diabetes Technology: Standards of Care in Diabetes-2023. Diab Care. 2023;46:111. Doi: 10.2337/dc23-S007.

16. IDF Diabetes Atlas, 10th Edition. Available at: https://diabetesatlas.org. Accessed 7th Jan, 2022.

17. Polonsky W.H., Fisher L., Schikman C.H., et al. A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study. Diab Technol Ther. 2011;13:797–802. Doi: 10.1089/dia.2011.0073.

18. Di Molfetta S., Bosi E., Ceriello A., et al. Structured self-monitoring of blood glucose is associated with more appropriate therapeutic interventions than unstructured self-monitoring: A novel analysis of data from the PRISMA trial. Diab Res Clin Pract. 2021;181:109070. Doi: 10.1016/j.diabres.2021.109070.

19. Battelino T., DanneT., Bergenstal R.M., et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range. Diab Care. 2019;42:1593–603. Doi: 10.2337/dci19-0028.

20. Russo G.T., Andreozzi F., Calabrese M., et al. Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative. Diab Res Clin Pract. 2022;194:110158. Doi: 10.1016/j.diabres.2022.110158.

21. Verma D., Bahurupi Y., Kant R., et al. Effect of mHealth Interventions on Glycemic Control and HbA1c Improvement among Type II Diabetes patients in Asian population: A systematic review and meta-analysis. Indian J Endocrinol Metab. 2021;25:484–92. Doi: 10.4103/ijem.ijem_387_21.

22. Fisher L., Fortmann A., Stuhr A. Can a Basic Management App Paired With A Glucose Meter Help Reduce Glucose Levels Among Adults With Type 2 Diabetes? The REALL Study. J Diab Sci Technol. 2024;18(1):99–105. Doi: 10.1177/19322968221096163.

23. Steinhubl S.R., Muse E.D., Topol E.J. Can mobile health technologies transform health care? JAMA. 2013;310(22):2395–6. Doi: 10.1001/jama.2013.281078.

24. Garabedian L.F., Ross-Degnan D., Wharam J.F. Mobile phone and smartphone technologies for diabetes care and self-management. Curr Diab Rep. 2015;15(12):109. Doi: 10.1007/s11892-015-0680-8.

25. Vaala S.E., Hood K.K., Laffel L., et al. Use of commonly available technologies for diabetes information and self-management among adolescents with type 1 diabetes and their parents: a web-based survey study. Interact J Med Res. 2015;4(4):e24. Doi: 10.2196/ijmr.4504.

26. Liang X., Wang Q., Yang X., et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diab Med. 2011;28(4):455–63. Doi: 10.1111/j.1464-5491.2010.03180.x.

27. Arambepola C., Ricci-Cabello I., Manikavasagam P., et al. The impact of automated brief messages promoting lifestyle changes delivered via mobile devices to people with type 2 diabetes: a systematic literature review and meta-analysis of controlled trials. J Med Internet Res. 2016;18(4):e86. Doi: 10.2196/jmir.5425.

28. Handa T., Onoue T., Kobayashi T., et al. Effects of Digitization of Self-Monitoring of Blood Glucose Records Using a Mobile App and the Cloud System on Outpatient Management of Diabetes: Single-Armed Prospective Study. JMIR. Diabetes. 2024;9:e48019. Doi: 10.2196/48019.

29. Bellfield E.J., Sharp L.K., Xia Y., Gerber B.S. Use of a mobile app to facilitate blood glucose monitoring in adolescents with type 1 diabetes: single-subject nonrandomized clinical trial. JMIR. Diabetes. 2018;3(1):e3. Doi: 10.2196/diabetes.8357.

30. Hao Y., Xu H. A prospective cohort study on the management of young patients with newly diagnosed type 2 diabetes using mobile medical applications. Diab Ther. 2018;9(5):2099–106. Doi: 10.1007/s13300-018-0506-1.

31. Дианов О.А., Майоров Р.В., Горшкова М.А., Колесникова Ю.В. Точность измерения и интерференция при самоконтроле гликемии с помощью глюкометра САТЕЛЛИТ® ONLINE у больных сахарным диабетом. Эффективная фармакотерапия. 2023;19(34):24–30.